Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.28 EUR | -0.19% | -10.02% | +20.93% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 10-09-12 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Michael Smith
CMP | Compliance Officer | - | - |
Brent Gardner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jebediah Ledell
COO | Chief Operating Officer | 49 | 21-11-30 |
Stefanie Solomon
CMP | Compliance Officer | - | - |
Anisha Wharton
LAW | General Counsel | - | 20-12-31 |
Danielle Holland
LAW | General Counsel | - | - |
David Crist
SAM | Sales & Marketing | - | 20-10-18 |
Corporate Officer/Principal | - | 17-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 10-09-12 | |
Jaywin Lee
BRD | Director/Board Member | - | 23-01-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,763,127 | 34,693,418 ( 99.80 %) | 0 | 99.80 % |
Company contact information
AVEO Pharmaceuticals, Inc.
1 Marina Park Drive 12th floor
02210, Boston
+857 400 0101
http://www.aveooncology.comSector
1st Jan change | Capi. | |
---|---|---|
-1.64% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
+61.28% | 26.41B | |
-22.81% | 14.34B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B |
- Stock Market
- Equities
- AVEO Stock
- VPA Stock
- Company AVEO Pharmaceuticals, Inc.